These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 3362878

  • 21. Heterotransplantation of human urinary bladder cancers in nude mice.
    Naito S, Iwakawa A, Tanaka K, Momose S, Hirata K, Emoto K, Sakamoto K, Hara S.
    Invest Urol; 1981 Jan; 18(4):285-8. PubMed ID: 7451092
    [Abstract] [Full Text] [Related]

  • 22. Morphological, biological, and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and in nude mice.
    Kyriazis AA, Kyriazis AP, McCombs WB, Peterson WD.
    Cancer Res; 1984 Sep; 44(9):3997-4005. PubMed ID: 6744315
    [Abstract] [Full Text] [Related]

  • 23. [Establishment of cell lines (KH-39, KN-41, and KW-103) from human kidney and bladder cancer and their characteristics].
    Naito K, Hisazumi H, Kanokogi M, Katoh M, Nakazima K, Tsukahara K, Kobayashi T, Kuroda K, Matsubara F.
    Nihon Hinyokika Gakkai Zasshi; 1982 Aug; 73(8):1019-31. PubMed ID: 7154478
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of invasive bladder cancer (lymph node negative, metastases negative).
    Chisholm GD.
    Prog Clin Biol Res; 1989 Aug; 303():559-61. PubMed ID: 2780661
    [No Abstract] [Full Text] [Related]

  • 25. A new in vivo model to study invasion and metastasis of human bladder carcinoma.
    Ahlering TE, Dubeau L, Jones PA.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6660-5. PubMed ID: 3677100
    [Abstract] [Full Text] [Related]

  • 26. Molecular targeting and pharmacogenomics in the management of advanced bladder cancer.
    Raghavan D.
    Cancer; 2003 Apr 15; 97(8 Suppl):2083-9. PubMed ID: 12673700
    [Abstract] [Full Text] [Related]

  • 27. [Evaluation of the anticancer effect of cisplatin and etoposide against nude mice transplanted urological malignant tumors].
    Gotoh A, Mizuno Y, Matsuwari S, Kitazawa S, Maeda S, Arakawa S, Kamidono S.
    Gan To Kagaku Ryoho; 1994 May 15; 21(6):899-902. PubMed ID: 8185353
    [No Abstract] [Full Text] [Related]

  • 28. Response of bladder carcinoma cells to TRAIL and antisense oligonucleotide, Bcl-2 or clusterin treatments.
    Sun B, Moibi JA, Mak A, Xiao Z, Roa W, Moore RB.
    J Urol; 2009 Mar 15; 181(3):1361-71. PubMed ID: 19157446
    [Abstract] [Full Text] [Related]

  • 29. [Studies of heterotransplantation of transplantable human urogenital malignant neoplasms. Part VII. Combined chemo-radiation therapy of human urinary bladder cancer and human prostatic cancer transplantable to nude mice].
    Hasegawa J.
    Nihon Hinyokika Gakkai Zasshi; 1985 Apr 15; 76(4):473-82. PubMed ID: 4032908
    [No Abstract] [Full Text] [Related]

  • 30. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug 15; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 31. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
    Kelland LR.
    Eur J Cancer; 2004 Apr 15; 40(6):827-36. PubMed ID: 15120038
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Antitumor efficacy of N1,N11-diethylnorspermine on a human bladder tumor xenograft in nude athymic mice.
    Sharma A, Glaves D, Porter CW, Raghavan D, Bernacki RJ.
    Clin Cancer Res; 1997 Aug 15; 3(8):1239-44. PubMed ID: 9815805
    [Abstract] [Full Text] [Related]

  • 34. Developing innovative strategies for advanced transitional cell carcinoma of the bladder.
    Pollera CF, Nelli F.
    Expert Rev Anticancer Ther; 2006 Jan 15; 6(1):83-92. PubMed ID: 16375647
    [Abstract] [Full Text] [Related]

  • 35. Prevention of bladder tumor formation in mice by a novel bone marrow-derived factor, reptimed.
    Khandaker MH, Kadhim SA, Ichim TE, Howson-Jan K, Chin J, Singhal SK.
    Anticancer Res; 2000 Jan 15; 20(1A):183-9. PubMed ID: 10769653
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer.
    Le Visage C, Rioux-Leclercq N, Haller M, Breton P, Malavaud B, Leong K.
    J Urol; 2004 Mar 15; 171(3):1324-9. PubMed ID: 14767342
    [Abstract] [Full Text] [Related]

  • 37. Chemotherapy of metastatic bladder cancer.
    Yagoda A.
    Cancer; 1980 Apr 15; 45(7 Suppl):1879-88. PubMed ID: 7189443
    [No Abstract] [Full Text] [Related]

  • 38. Purinergic receptor-mediated effects of ATP in high-grade bladder cancer.
    Shabbir M, Ryten M, Thompson C, Mikhailidis D, Burnstock G.
    BJU Int; 2008 Jan 15; 101(1):106-12. PubMed ID: 17941929
    [Abstract] [Full Text] [Related]

  • 39. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001 Jan 15; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.